浏览全部资源
扫码关注微信
1.北京市西城区广外医院中药房,北京 100055
2.中日友好医院药学部,北京 100029
3.北京中医药大学东直门医院药学部,北京 100028
鲁爽,女,41岁,大学本科,副主任药师。研究方向:临床中药学。
华国栋,E-mail:zhaojhuagd@126.com
纸质出版日期:2024-12-25,
收稿日期:2023-12-21,
移动端阅览
鲁爽,柳芳,华国栋.海藻配伍甘草的临床应用情况及安全性评价[J].北京中医药,2024,43(12):1441-1443.
LU Shuang,LIU Fang,HUA Guodong.Clinical application and safety evaluation of seaweed combined with licorice[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(12):1441-1443.
鲁爽,柳芳,华国栋.海藻配伍甘草的临床应用情况及安全性评价[J].北京中医药,2024,43(12):1441-1443. DOI: 10.16025/j.1674-1307.2024.12.024.
LU Shuang,LIU Fang,HUA Guodong.Clinical application and safety evaluation of seaweed combined with licorice[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(12):1441-1443. DOI: 10.16025/j.1674-1307.2024.12.024.
目的
2
评价海藻配伍甘草的临床应用情况及安全性。
方法
2
选择2017年1月1日—2023年1月31日北京市西城区广外医院和中日友好医院门诊与住院病历资料,筛选海藻与甘草配伍的处方,分析具体给药情况及患者用药前后身体状况。
结果
2
患者145例次,共计367张处方存在海藻和甘草配伍使用,其中179张(48.78%)处方应用质量比是1∶1,连续时间最长为707 d。查看145例患者开始使用该配伍前1个月至用药结束后1个月的检验指标,未发现与海藻与甘草配伍相关的不良反应。
结论
2
海藻与甘草的配伍,临床使用时应严谨辨证,斟酌用量及比例,同时加强安全性监测。
Objective
2
To evaluate the clinical application and safety of combination of seaweed and licorice.
Methods
2
A retrospective analysis was conducted on the medical records selected from outpatient and inpatient departments of Guangwai Hospital, Xicheng District of Beijing and China-Japan Friendship Hospital from January 1, 2017 to January 31, 2023 involving the presciptions using seaweed and licorice. The specific medication situation and the physical condition of patients before and after medication were analyzed.
Results
2
There were 145 patients with a total of 367 prescriptions that included seaweed and licorice used in compatibility, among which, 179 prescriptions (48.78%) were applied in a mass ratio of 1∶1,the longest duration of continuous use was 707 days.Retrospectively reviewing the test indicators of the 145 patients from one month before to one month after using the combination revealed no adverse reactions related to the pairing of the two drugs.
Conclusion
2
When the combination of seaweed and licorice were used clinically, differential diagnosis should be strictly made and the dosage and ratio be considered and the safety monitoring be strenghened.
十八反海藻甘草临床应用安全性
eighteen incompatibilityseaweedlicoriceclinical applicationsecurity
王利敏,王青华,关新军,等.反药药对甘草海藻古方合用分析[J].浙江中医杂志,2018,53(6):463.
蒲志孝.蒲辅周轶事[J].山东中医杂志,1985,4(2):29-31.
朱良春,何绍奇.为“十八反”平反[J].中国中医基础医学杂志,1998(4):16.
冯克久,吕英.李可从中气论治消化道肿瘤[J].中国民间疗法,2021,29(8):46-49.
陈绍红,钟赣生,刘佳,等.国家级名老中医临证应用海藻甘草反药组合的处方特征[J].中国临床医生杂志,2015,(6):89-92,93.
王旭,徐奚如,周学平.海藻与甘草配伍临床应用探析[J].中医杂志,2013,54(1):29-31.
吕艳敏,贺成,李娜,等.海藻甘草反药组合配伍对海藻玉壶汤中5种活性成分溶出含量影响[J].辽宁中医药大学学报,2020,22(1):59-62.
颜辉,王国基,陈坚.不同比例海藻与甘草配伍对大鼠的毒性研究[J].中国中药杂志,2007,32(16):1700-1703.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构